PBH logo

Prestige Consumer Healthcare Inc. (PBH)

$48.22

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PBH

Market cap

$2.29B

EPS

3.24

P/E ratio

13.5

Price to sales

2.07

Dividend yield

--

Beta

0.30505

Price on PBH

Previous close

$48

Today's open

$47.59

Day's range

$47.43 - $48.79

52 week range

$41.77 - $71.07

Profile about PBH

CEO

Ronald M. Lombardi

Employees

890

Headquarters

Tarrytown, NY

Exchange

New York Stock Exchange

Shares outstanding

47397106

Issue type

Common Stock

PBH industries and sectors

Consumer Staples

Consumer Products - Healthcare

News on PBH

Prestige Consumer Healthcare Q2 Earnings Call Highlights

Prestige Consumer Healthcare NYSE: PBH reported fiscal second-quarter revenue growth of 22.7%, driven by its recent acquisitions, but lowered its full-year outlook as production disruptions continued to constrain its Clear Eyes brand.

news source

MarketBeat • Nov 8, 2026

news preview

Prestige Consumer Healthcare Inc. (PBH) Q2 2027 Earnings Call Transcript

Prestige Consumer Healthcare Inc. ( PBH ) Q2 2027 Earnings Call November 5, 2026 8:30 AM EST Company Participants Philip Terpolilli - Director of Investor Relations Ron Lombardi - Chairman, President & CEO Christine Sacco - CFO & COO Conference Call Participants Keith Devas - Jefferies LLC, Research Division Susan Anderson - Canaccord Genuity Corp., Research Division Rupesh Parikh - Oppenheimer & Co. Inc., Research Division David Shakno - William Blair & Company L.L.C., Research Division Mitchell Pinheiro - Sturdivant & Co., Inc., Research Division Presentation Operator Good day, and thank you for standing by.

news source

Seeking Alpha • Nov 7, 2026

news preview

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results

TARRYTOWN, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first half fiscal 2027 ended September 30, 2026.

news source

GlobeNewsWire • Nov 5, 2026

news preview

Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $1.07 per share a year ago.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Riverwater Small Cap Strategy Q3 2026 Portfolio Update

During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors include AtriCure and Red Violet; top detractors include Kodiak Gas Services and PDF Solutions. We initiated a position in IRadimed at the start of the quarter, replacing Talkspace after it was acquired.

news source

Seeking Alpha • Oct 28, 2026

news preview

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?

PBH's brand-building, acquisitions and e-commerce growth support fiscal 2027 revenue gains, but competition and currency risks remain key challenges.

news source

Zacks Investment Research • Oct 15, 2026

news preview

Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on Thursday, November 5, 2026 before the opening of the market.

news source

GlobeNewsWire • Oct 14, 2026

news preview

Best Value Stocks to Buy for October 1st

BP and PBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 1, 2026.

news source

Zacks Investment Research • Oct 1, 2026

news preview

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds

While 63% say women are more comfortable discussing intimate wellness than five years ago, new research reveals a gap between cultural progress and personal comfort TARRYTOWN, N.Y., Sept. 30, 2026 /PRNewswire/ -- Women may be talking more openly about intimate health and wellness, but that does not necessarily mean the discomfort has disappeared.

news source

PRNewsWire • Sep 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Prestige Consumer Healthcare Inc.

Open an M1 investment account to buy and sell Prestige Consumer Healthcare Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PBH on M1